Feature Channels: Vaccines

Filters close
Released: 23-Jun-2021 3:55 PM EDT
Cooperative Extension grant aims to vaccinate NYS’ vulnerable
Cornell University

A two-year, $200,000 grant from the USDA and the Extension Foundation to Cornell University researchers aims to help promote vaccine confidence and uptake in vulnerable communities in eight New York counties, both upstate and downstate.

Newswise:Video Embedded covid-19-vaccine-hesitancy-dr-vin-gupta-narrates-new-american-thoracic-society-video
VIDEO
Released: 23-Jun-2021 9:40 AM EDT
COVID-19 Vaccine Hesitancy: Dr. Vin Gupta Narrates New American Thoracic Society Video
American Thoracic Society (ATS)

The American Thoracic Society rolls out a new video to address vaccine hesitancy and answer common questions amid the COVID-19 pandemic.

18-Jun-2021 11:00 AM EDT
Had COVID-19? One Vaccine Dose Enough; Boosters For All, Study Says
American Chemical Society (ACS)

A new study in ACS Nano supports increasing evidence that people who had COVID-19 need only one vaccine dose, and that boosters could be necessary for everyone in the future.

Released: 22-Jun-2021 4:45 PM EDT
Penn Medicine to Use $1M from City of Philadelphia for Additional Community Vaccination Clinics
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine will continue its collaboration with the West and Southwest Philadelphia communities to operate a series of COVID-19 vaccine clinics in partnership with community organizations, faith-based institutions, restaurants, barbershops, and even professional sports teams thanks to $1 million in funding from the City of Philadelphia, in partnership with PMHCC.

22-Jun-2021 12:00 PM EDT
Study Testing How Well COVID-19 Vaccine Prevents Infection and Spread of SARS-CoV-2 Among University Students Now Expands to Include Young Adults Beyond the University Setting
Covid-19 Prevention Network (CoVPN)

The Prevent COVID U study, which launched in late March 2021 to evaluate SARS-CoV-2 infection and transmission among university students vaccinated with the Moderna COVID-19 Vaccine, has expanded beyond the university setting to enroll young adults ages 18 through 29 years and will now also include people in this age group who choose not to receive a vaccine.

Released: 22-Jun-2021 8:30 AM EDT
Engineering Nanobodies As Lifesavers When SARS-CoV-2 Variants Attack
Ohio State University

Scientists are pursuing a new strategy in the protracted fight against the SARS-CoV-2 virus by engineering nanobodies that can neutralize virus variants in two different ways.

Released: 21-Jun-2021 3:45 PM EDT
Rare Neurological Disorder Documented Following COVID-19 Vaccination
American Neurological Association (ANA)

In two separate articles in the Annals of Neurology, clinicians in India and England report cases of a rare neurological disorder called Guillain-Barré syndrome after individuals were vaccinated against COVID-19.

Newswise:Video Embedded virtual-event-for-june-17-11am-edt-covid-19-vaccines-and-male-fertility
VIDEO
Released: 18-Jun-2021 8:55 AM EDT
VIDEO AND TRANSCRIPT AVAILABLE: Vaccines and Male Fertility Event for June 17, 2021
Newswise

This upcoming JAMA-published study examined whether the COVID-19 vaccine impacts male fertility.

Released: 17-Jun-2021 4:10 PM EDT
Vaccination, Previous Infection, Protect Against COVID-19 gamma/P.1 Variant in Animal Model
University of Wisconsin-Madison

In a new study using variant virus recovered from one of the original travelers, researchers in the U.S. and Japan have found that vaccination with an mRNA vaccine induces antibody responses that would protect humans from infection with the gamma/P.1 variant.

Newswise:Video Embedded university-of-miami-miller-school-study-shows-covid-19-mrna-vaccines-do-not-impact-male-fertility
VIDEO
Released: 17-Jun-2021 11:00 AM EDT
University of Miami Miller School Study Shows COVID-19 mRNA Vaccines Do Not Impact Male Fertility
University of Miami Health System, Miller School of Medicine

The Pfizer and Moderna mRNA COVID-19 vaccines is safe for male reproduction, according to a new study by University of Miami Miller School of Medicine researchers published in JAMA , the most widely circulated general medical journal in the world.

Newswise: “ChulaCov19” Thailand’s First COVID-19 Vaccine Has Been Tested on Humans
Released: 17-Jun-2021 8:55 AM EDT
“ChulaCov19” Thailand’s First COVID-19 Vaccine Has Been Tested on Humans
Chulalongkorn University

On June 14, 2021 at Bhumisirimangalanusorn Building, Chulalongkorn Memorial Hospital, the Thai Red Cross Society, the Faculty of Medicine and the Chula Vaccine Research Center (CVRC), Faculty of Medicine, Chulalongkorn University conducted its first phase of clinical trial on volunteers who have passed the screening process and deemed to be in good health. The process is continuing on to phase 2 to monitor immunity reactions to the ChulaCov19 vaccine under the supervision of medical experts, doctors, nurses and the research team.

Newswise: In Show of COVID-19 Vaccine Confidence, 96% of America’s Ophthalmologists Already Vaccinated
Released: 16-Jun-2021 3:50 PM EDT
In Show of COVID-19 Vaccine Confidence, 96% of America’s Ophthalmologists Already Vaccinated
American Academy of Ophthalmology (AAO)

The American Academy of Ophthalmology is calling on its members to continue to build confidence in COVID-19 vaccines and encourage people to get vaccinated, including their staff.

Released: 16-Jun-2021 8:00 AM EDT
Two COVID-19 Vaccines Show Safety, Strong Immunity in Infant Model
University of North Carolina School of Medicine

The Moderna mRNA vaccine and a protein-based vaccine candidate elicited durable neutralizing antibody responses to SARS-CoV-2 in pre-clinical research. There were no adverse effects.

Newswise: Data and Safety Review Board Reports How it Monitored the COVID-19 Vaccine Trials
Released: 15-Jun-2021 2:55 PM EDT
Data and Safety Review Board Reports How it Monitored the COVID-19 Vaccine Trials
University of Alabama at Birmingham

Evaluation of three vaccine candidates during the COVID-19 pandemic fell to 12 experts of the federally appointed COVID-19 Vaccine Data and Safety Monitoring Board. This team has now taken the unusual step of publishing details of their review process in The Journal of Infectious Diseases.

Newswise: SARS-CoV-2 Worldwide Replication Drives Rapid Rise and Selection of Mutations
Released: 15-Jun-2021 11:40 AM EDT
SARS-CoV-2 Worldwide Replication Drives Rapid Rise and Selection of Mutations
UCLA Fielding School of Public Health

The number of COVID-19 variants is growing rapidly, so much that the scale and scope of mutation may pose a threat to the continuing successful use of the current vaccines and therapies. The findings, by an international team that includes University of California researchers, are being published in the June edition of the peer-reviewed journal EMBO Molecular Medicine. The pace of variation of the SARS-CoV-2 virus strains makes plain the threat that rapidly evolving new strains might give rise to escape variants, capable of limiting the efficacy of vaccines, therapies, and diagnostic tests.

Released: 15-Jun-2021 9:35 AM EDT
Southwest National Primate Research Center at Texas Biomed receives $37 million NIH grant
Texas Biomedical Research Institute

The Southwest National Primate Research Center (SNPRC) at Texas Biomed has been awarded more than $37 million from the National Institutes of Health to continue operations into 2026. The P51 grant, given by the NIH Office of Research Infrastructure Programs, provides essential funding to house and care for nearly 2,500 non-human primates that are part of life-science research programs at Texas Biomed and partners around the globe.

Newswise: For Transplant Recipients, Third Time May Be the Charm for Better COVID Vaccine Protection
Released: 14-Jun-2021 5:15 PM EDT
For Transplant Recipients, Third Time May Be the Charm for Better COVID Vaccine Protection
Johns Hopkins Medicine

In a study published today in the Annals of Internal Medicine, Johns Hopkins Medicine researchers say they believe that, for the first time, there is evidence to show that three doses of vaccine increase antibody levels against SARS-CoV-2 — the virus that causes COVID 19 — more than the standard two-dose regimen for people who have received solid organ transplants.

Newswise: Masking, breakthrough infections and telehealth: Keck Medicine of USC experts on life after June 15
Released: 14-Jun-2021 2:05 PM EDT
Masking, breakthrough infections and telehealth: Keck Medicine of USC experts on life after June 15
Keck Medicine of USC

June 15 is a banner day in California. Most COVID-19 statewide restrictions will be eliminated, including physical distancing and in many situations, mask mandates. How will life change and how will it stay the same? Keck Medicine of USC experts weigh in on what to expect next in the golden state.

Newswise: California Reopening: Experts Say Keep Masks Handy
Released: 14-Jun-2021 10:35 AM EDT
California Reopening: Experts Say Keep Masks Handy
Cedars-Sinai

This week brings a milestone to pandemic-weary Californians: As of June 15, California public health guidelines that have been in place during the 15 months of the COVID-19 pandemic will be relaxed. Those who are fully vaccinated against COVID-19 will be able to go mask-free in most situations, but Cedars-Sinai infectious disease experts suggest masks, an important tool in preventing transmission of the virus, will be with us a while longer.

Released: 14-Jun-2021 9:45 AM EDT
People with Health Insurance Vaccinated More Than Those Without, Survey Finds
Rutgers University-New Brunswick

People with health insurance are receiving the COVID-19 vaccine at a higher rate than those without insurance, despite the vaccine being free, according to a national survey from the Edward J. Bloustein School of Planning and Public Policy at Rutgers University-New Brunswick.

Newswise: FresnoSTateVaxImage2.jpg
Released: 10-Jun-2021 5:25 PM EDT
CSU Campuses Join COVID-19 College Vaccine Challenge
California State University (CSU) Chancellor's Office

The CSU pledges to be a Vaccine Champion University as part of new White House effort aimed at increasing vaccinations for younger Americans.

Released: 10-Jun-2021 10:55 AM EDT
NCCN Cancer Experts Answer Questions about COVID-19 Vaccines
National Comprehensive Cancer Network® (NCCN®)

National Comprehensive Cancer Network’s patient information team provides a patient and caregiver version of recently-updated, evidence-based expert consensus recommendations for vaccinating people with cancer against COVID-19.

Newswise: New treatment demonstrated for people with vaccine clots
8-Jun-2021 10:50 AM EDT
New treatment demonstrated for people with vaccine clots
McMaster University

The treatment’s effectiveness was described in a report describing three Canadian patients who received the AstraZeneca vaccine, and who subsequently developed VITT. Two suffered clotting in their legs and the third had clots blocking arteries and veins inside their brain.

Newswise: The Medical Minute: Vaccinating kids against COVID-19 protects them, their communities
Released: 9-Jun-2021 3:40 PM EDT
The Medical Minute: Vaccinating kids against COVID-19 protects them, their communities
Penn State Health

Is the Pfizer BioNTech vaccine really safe for children ages 12 and up? A Penn State Health expert gives an emphatic yes.

Newswise: Single-Shot COVID-19 Vaccine Generates Robust Immune Responses Against COVID-19 Variants
Released: 9-Jun-2021 7:05 AM EDT
Single-Shot COVID-19 Vaccine Generates Robust Immune Responses Against COVID-19 Variants
Beth Israel Deaconess Medical Center

In a new study published in Nature, Dan Barouch, MD, PhD, Director of BIDMC's Center for Virology and Vaccine Research, and colleagues report on the antibody and cellular immune responses generated by the Ad26.COV2.S vaccine against the original viral strain and against SARS-CoV-2 variants of concern. The team found that this vaccine induced immune responses against all the viral variants.

Newswise: Study Finds COVID-19 Vaccines Safe for IBD Patients
Released: 8-Jun-2021 6:05 PM EDT
Study Finds COVID-19 Vaccines Safe for IBD Patients
Cedars-Sinai

Patients with inflammatory bowel diseases (IBD) do not appear to have increased risk of side effects from the Pfizer or Moderna COVID-19 vaccines, according to a recent Cedars-Sinai study published online and upcoming in print in the American Journal of Gastroenterology. In fact, those being treated with advanced immune-modifying therapies may experience them less often than the general population.

Newswise: University Hospitals Releases UH Vaccine Playbook
Released: 8-Jun-2021 3:15 PM EDT
University Hospitals Releases UH Vaccine Playbook
University Hospitals Cleveland Medical Center

The UH Vaccine Playbook serves as a guide for those who are not yet “vaccine ready.”

Newswise: Mandating vaccination could reduce voluntary compliance
Released: 7-Jun-2021 4:10 PM EDT
Mandating vaccination could reduce voluntary compliance
Santa Fe Institute

A new study based on evidence from Germany and on a model of the dynamic nature of people’s resistance to COVID-19 vaccination sounds an alarm: mandating vaccination could have a substantial negative impact on voluntary compliance.

Released: 7-Jun-2021 5:05 AM EDT
Covid-19 vaccines also protect unvaccinated family members
Aalto University

Researchers at the Helsinki Graduate School of Economics have found that the Pfizer-BioNTech and Moderna Covid-19 vaccines protect both vaccinated individuals and their unvaccinated adult household members against SARS-CoV-2 infections. The study, not yet peer-reviewed, used Finnish administrative datasets to examine the link between mRNA-based Covid-19 vaccines and infection risk among vaccinated individuals as well as their unvaccinated family members.

Released: 4-Jun-2021 5:05 PM EDT
Most New Jerseyans Support Fully Reopening Public Schools in Fall, Requiring Vaccinations for Healthcare Workers, Rutgers Poll Shows
Rutgers University-New Brunswick

As vaccination rates increase and prospects of normal life return more than a year into the coronavirus pandemic, New Jerseyans differ on various aspects of this “new normal” and how comfortable they feel, according to the latest Rutgers-Eagleton Poll.

Released: 4-Jun-2021 1:05 PM EDT
New study into green tea's potential to help tackle COVID-19
Swansea University

As India continues to be ravaged by the pandemic, a Swansea University academic is investigating how green tea could give rise to a drug capable of tackling Covid-19.

Released: 4-Jun-2021 12:05 PM EDT
Dollars to donuts: What will it take to get more of the U.S. vaccinated against COVID-19?
Michigan Medicine - University of Michigan

Prizes, lotteries, discounts and freebies for COVID-19 vaccination may help overcome vaccine hesitancy and reward the vaccinated too, but it's important to learn from this moment to inform other preventive health care, an expert says.

Newswise: Lessons from the last pandemic point the way toward universal flu vaccines
Released: 4-Jun-2021 6:00 AM EDT
Lessons from the last pandemic point the way toward universal flu vaccines
University of Chicago Medical Center

A new study from the University of Chicago and Scripps Research Institute shows that during the last great pandemic—2009’s H1N1 influenza pandemic—people developed strong, effective immune responses to stable, conserved parts of the virus.

Released: 3-Jun-2021 11:05 AM EDT
About One in Six New Jerseyans Say They Won’t Get COVID-19 Vaccine
Rutgers University-New Brunswick

Seventy-three percent of New Jerseyans say they have received at least one dose of a COVID-19 vaccine, and while another 10 percent say they will likely roll up their sleeve for it, 16 percent remain unwilling, according to the latest Rutgers-Eagleton Poll.

Newswise: Story Tips from Johns Hopkins Experts on COVID-19
Released: 3-Jun-2021 11:00 AM EDT
Story Tips from Johns Hopkins Experts on COVID-19
Johns Hopkins Medicine

NEWS STORIES IN THIS ISSUE: -Physician and Musician: Johns Hopkins Doctor Brings Passion for Music to Medicine During Pandemic -Rapid, At-Home Blood Test Could Confirm COVID-19 Vaccination in Minutes -What to Expect and Prepare for As You Return to Regular Health Care Appointments -Study Suggests Sudden Hearing Loss Not Associated with COVID-19 Vaccination -Vaccination May Not Rid COVID-19 Risk for Those with Rheumatic, Musculoskeletal Diseases

Newswise: Alexander_WEB-1-768x512.jpg
Released: 2-Jun-2021 4:25 PM EDT
FSU expert available to discuss vaccine hesitancy
Florida State University

By: Bill Wellock | Published: June 2, 2021 | 1:16 pm | SHARE: Rollout of the COVID-19 vaccine is continuing, but some people are hesitant to get vaccinated against the disease.Dr. Christie Alexander, an associate professor in the Department of Family Medicine and Rural Health in the Florida State University College of Medicine and a past president of the Florida Academy of Family Physicians, recently participated in an expert panel about how to win over vaccine skeptics.

Newswise: Massachusetts Dermatologist Establishes Covid-19  Vaccination Site for School Nurses
Released: 2-Jun-2021 4:05 PM EDT
Massachusetts Dermatologist Establishes Covid-19 Vaccination Site for School Nurses
American Academy of Dermatology

Local board-certified dermatologist Louis Kuchnir, MD, FAAD, was honored as an American Academy of Dermatology Patient Care Hero for establishing a COVID-19 vaccination site in Marlborough, Mass. for school nurses at a time early in the vaccine rollout when vaccines were in short supply.

Newswise: Illinois Dermatologist Organizes Local Effort to Vaccinate Frontline Health Care Workers
Released: 2-Jun-2021 3:50 PM EDT
Illinois Dermatologist Organizes Local Effort to Vaccinate Frontline Health Care Workers
American Academy of Dermatology

Local board-certified dermatologist Amy J. Derick, MD, FAAD, was honored as a Patient Care Hero by the American Academy of Dermatology for her efforts to improve access to COVID-19 vaccines for frontline health care professionals in Illinois after realizing they could not obtain vaccinations at the start of the vaccine rollout in December 2020 and January 2021.

Newswise: UCLA Model Identifies Neighborhoods That Should Have Priorities as Re-Opening Begins
Released: 2-Jun-2021 11:15 AM EDT
UCLA Model Identifies Neighborhoods That Should Have Priorities as Re-Opening Begins
UCLA Fielding School of Public Health

A UCLA team has developed a predictive model that pinpoints which populations in which neighborhoods of Los Angeles County are most at risk from COVID-19, and, by extension, which should be prioritized for vaccines. The work is applicable nationally.

Released: 2-Jun-2021 10:10 AM EDT
Patients Taking Anti-Inflammatory Drugs Respond Less Well to COVID-19 Vaccine
NYU Langone Health

One-quarter of people who take the drug methotrexate for common immune system disorders — from rheumatoid arthritis to multiple sclerosis — mount a weaker immune response to a COVID-19 vaccine, a new study shows.

Newswise: Research Shows Plunge in Childhood Vaccination Rates in Texas During Pandemic
Released: 1-Jun-2021 2:40 PM EDT
Research Shows Plunge in Childhood Vaccination Rates in Texas During Pandemic
UCLA Fielding School of Public Health

A team of researchers from universities in California and Texas has found immunization rates for children in Texas for a wide range of diseases, including polio and measles, have dropped steeply during the COVID-19 pandemic.

Newswise: COVID-19 Simulation Shows Importance of Continued Safety Efforts During Vaccine Distribution
Released: 1-Jun-2021 1:40 PM EDT
COVID-19 Simulation Shows Importance of Continued Safety Efforts During Vaccine Distribution
University of North Carolina Health Care System

Research published by JAMA Network Open shows how non-pharmaceutical interventions (NPIs) like mask wearing and physical distancing can help prevent spikes in COVID-19 cases as populations continue to get vaccinated.

Newswise: College of Medicine, Hershey Medical Center join clinical trial evaluating allergic reactions to COVID-19 vaccines
Released: 1-Jun-2021 9:40 AM EDT
College of Medicine, Hershey Medical Center join clinical trial evaluating allergic reactions to COVID-19 vaccines
Penn State College of Medicine

Researchers at Penn State College of Medicine are participating in a national clinical trial evaluating whether people who have previously experienced severe allergic reactions are at increased risk for an immediate, systemic allergic reaction to the Moderna or Pfizer-BioNTech COVID-19 vaccines.

Newswise: UAB’s new Immunology Institute provides new avenues for discovery
Released: 27-May-2021 4:05 PM EDT
UAB’s new Immunology Institute provides new avenues for discovery
University of Alabama at Birmingham

UAB has established an interdisciplinary hub for research and patient care in the study of immunity.

Newswise: Low on Antibodies, Blood Cancer Patients Can Fight off COVID-19 with T Cells
Released: 26-May-2021 8:25 PM EDT
Low on Antibodies, Blood Cancer Patients Can Fight off COVID-19 with T Cells
Perelman School of Medicine at the University of Pennsylvania

Antibodies aren’t the only immune cells needed to fight off COVID-19 — T cells are equally important and can step up to do the job when antibodies are depleted, suggests a new Penn Medicine study of blood cancer patients with COVID-19 published in Nature Medicine.

Newswise: 266044_web.jpg
Released: 26-May-2021 3:55 PM EDT
Study shows SARS-CoV-2 variants unlikely to affect T cell responses
Hong Kong University of Science and Technology

In a new study, scientists at The Hong Kong University of Science and Technology (HKUST) have revealed that most T cell epitopes known to be targeted upon natural infection are seemingly unaffected by current SARS-CoV-2 variants.

Released: 26-May-2021 2:20 PM EDT
Study affirms that vaccines are safe for children and adults
RAND Corporation

A new study looking across a large body of research finds further evidence for the safety of vaccines that are Food and Drug Administration-approved and routinely recommended for children, adults and pregnant women.

Newswise: Polymer ‘wafers’ placed under the tongue could deliver vaccines of the future
Released: 26-May-2021 9:40 AM EDT
Polymer ‘wafers’ placed under the tongue could deliver vaccines of the future
University of Minnesota College of Science and Engineering

A team of researchers, led by a University of Minnesota associate professor, have developed a polymer “wafer” that, when placed under the tongue, can effectively deliver and preserve protein-based vaccines for diseases. The research could open the door for vaccines that can be more easily produced and distributed to communities around the world.


Showing results

150 of 2041

close
2.0906